Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03665168
Other study ID # 201800366
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2018
Est. completion date December 1, 2020

Study information

Verified date April 2024
Source University Medical Center Groningen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A nationwide, cross-sectional study, to determine the prevalence of symptoms of patients in the palliative phase in various care settings will be performed within a set period of two weeks in September 2018 and two weeks in November 2018. The participating settings will be selected by a total of seven coordinators, one for each consortium of palliative care in the Netherlands. To identify common combinations of symptoms and for multidimensional screening the Utrecht Symptom Diary-4 Dimensional (USD-4D) and Utrecht Symptom Diary (USD), a Dutch instrument based on the Edmonton Symptom Assessment Scale, will be used. The current protocol focuses on the cross-sectional study.


Description:

The Utrecht Symptom Diary-4 dimensional (USD-4D), a Dutch instrument based on the Edmonton Symptom Assessment Scale, will be used for multidimensional screening and assessment of intensity and prevalence of symptoms. The questionnaire assesses twelve symptoms: pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion. This is measured on a numeric scale from 0 (no complaints) to 10 (worst imaginable or intolerable). The prevalence of symptoms will be described by frequencies, dichotomizing symptom scores in absent (0 on NRS) or present (1 or higher on NRS). Symptom scores of 4 or higher on NRS are considered clinically relevant. There is a possibility to add two more complaints not enlisted and to prioritise the problems which should be addressed first by the HCP. Quality of life is assessed using a (un)well-being measure and the opportunity to score the experienced value of life. Finally, five multidimensional questions will screen for mental capacity ("draagkracht"), the relationship with loved ones and thoughts concerning end of life. These multidimensional questions will be filled out together with the HCP. Therefore the HCP decides beforehand whether those questions will be asked. The USD-4D will be filled out only once by participating patients without follow-up. The patients will be asked to fill out the following characteristics: age, gender, education level, cultural background, living situation, underlying disease, comorbidities, performance score, medication groups and interventions. The estimated time to fill out both questionnaires is fifteen to twenty-five minutes.


Recruitment information / eligibility

Status Completed
Enrollment 659
Est. completion date December 1, 2020
Est. primary completion date September 1, 2020
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Patient selection will be performed by health care providers in the participating settings. Inclusion Criterium: • Patients of whom the health care professional answers "no" to the question "Would I be surprised if this patient died in the next 12 months ?". Exclusion Criterium: •Patients unable or unwilling to self-assess their symptoms

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Netherlands University Medical Center Groningen Groningen

Sponsors (1)

Lead Sponsor Collaborator
University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of multiple, simultaneously occurring symptoms Prevalence of multiple, simultaneously occurring symptoms (symptom clusters) in patients in the palliative phase in Dutch care settings (GP practices, home care facilities, general and academic hospitals, hospices). 4 weeks
Secondary Prevalence of each separate symptom For each symptom assessed (pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion) we will ask patients to score how they feel. In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their experienced intensity of complaints. Zero represents 'no complaint at all' whereas the upper limit represents 'the worst (pain, nausea, etc.) ever possible'. 4 weeks
Secondary Clinically relevant symptoms For each symptom assessed (pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion) we will ask patients to score how they feel. In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their experienced intensity of complaints. Zero represents 'no complaint at all' whereas the upper limit represents 'the worst (pain, nausea, etc.) ever possible'. All scores of 4 and higher are considered clinically relevant. 4 weeks
Secondary Quality of life (single question with numeric rating scale) Opportunity to score the experienced quality of life with the question: "how do you feel at this moment?". In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their wellbeing. Zero represents 'feeling very well' whereas the upper limit (10)represents 'feeling very bad'. 4 weeks
Secondary Symptom burden (multidimensional questions of Utrecht Symptom Diary-4Dimensional) Five multidimensional theses will screen for mental capacity, the relationship with loved ones and thoughts concerning end of life. The following theses are presented:
I have the chance to be myself
I can bear what happens to me
I can let go of my loved ones
I am living a balanced life
Thoughts at the end of life gives me peace of mind
In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 that fits best to their experienced feeling. Zero represents 'totally agree' whereas the upper limit represents 'totally disagree'. These values will be descriptive, a higher or lower value is not necessarily a better or worse outcome.
4 weeks
Secondary Symptoms per care setting Number of participants with assessed complaints (pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion) per care setting (general practitioners practices, home care facilities, general and academic hospitals, hospices) 4 weeks
Secondary Symptoms per underlying disease Number of participants with assessed complaints (pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion) per underlying disease (most probably incurable cancer, chronic obstructive pulmonary disease, heart failure and end-stage renal disease). 4 weeks
See also
  Status Clinical Trial Phase
Withdrawn NCT03245658 - The Effect of Cannabis in Pancreatic Cancer Phase 2
Not yet recruiting NCT06328751 - Meditation With Virtual Reality for Cancer Pain Relief in the Pain Therapy and Palliative Care Service N/A
Recruiting NCT05883696 - Palliative Care Needs Among Elderly People at Emergency Department
Completed NCT01415934 - Statin Discontinuation in Advanced Illness N/A
Recruiting NCT04519632 - Paediatric Palliative Care Pain Management in the Community
Not yet recruiting NCT06110624 - The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management
Completed NCT04630743 - Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease N/A
Completed NCT05454644 - Effectiveness of a Person-centred Prescription Model at the End of Life N/A
Not yet recruiting NCT06329856 - Exploring Indications and Practices of Administering Artificial Hydration to Terminal Cancer Patients in Taiwan
Terminated NCT02581059 - Efficacy of Ginseng for Patients on Regorafenib Phase 2
Terminated NCT04251520 - The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients N/A
Withdrawn NCT06310889 - Evaluation of Palliative Care Co-treatment by Attending Physicians and Nurses: an Online Survey as Part of the Project
Completed NCT05640076 - Effects of a 24/7 Palliative Care Service Integration in a Metropolitan Area on Non-oncologic Patients